British inquiry finds COVID vaccine program saved hundreds of thousands of lives but calls for improved support for those who experienced adverse effects.
Multiple states are reducing Medicaid coverage for weight-loss drugs while federal health programs undergo policy modifications.
More than 125 million people face severe weather risks as tornado watches are issued across the Central U.S. while Hawaii deals with storm aftermath.
The FDA will hold a summer meeting to consider easing restrictions on seven peptide injections, following Health Secretary RFK Jr.'s advocacy for these unproven therapies.
A Florida doctor faces manslaughter charges after allegedly removing a patient's liver instead of spleen during surgery, resulting in the patient's death.
Testing revealed lead contamination at 50% of New Orleans playgrounds examined, prompting calls for $5 million in federal cleanup funding.
Hayam El Gamal was taken to emergency room after detention center allegedly delayed CT scan for weeks despite chest symptoms.
Pharmaceutical company Eli Lilly announced positive results from a late-stage clinical trial of its obesity medication showing reduced cardiovascular risks.
A major review concluded certain Alzheimer's drugs provide minimal clinical benefit, drawing criticism from experts who say the analysis was flawed.
Recent studies reveal declining overdose deaths and STIs alongside rising concerns about wildlife disease spillover and antibiotic resistance.
A Nebraska hospital shuttered its dialysis center despite state funding for rural healthcare, while a Colorado hospital trains staff as interpreters.
A judge's stay has blocked Trump administration changes to CDC vaccine guidance, affecting recommendations for flu and COVID shots.
The NHS implementation of Palantir data software has drawn criticism from lawmakers and internal staff warnings about public criticism of the rollout.
An unusual April heat wave is expected to challenge temperature records across the eastern United States on Wednesday, with cities like New York and Philadelphia forecast to reach the low 90s.
The FDA is asking Eli Lilly to collect more safety information on its newly approved weight-loss pill Foundayo, including potential liver and heart risks.
Page 1 of 17 (245 stories)